PRMT5 inhibitors and uses thereof
US-12583859-B2 · Mar 24, 2026 · US
This page is not indexed by search engines while we improve data quality.
Bartberger Michael D patents
Bartberger Michael D is listed as an inventor on 30 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Bartberger Michael D |
| Total patents | 30 |
| First publication | Jan 7, 2016 |
| Latest publication | Mar 24, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
US-2026078091-A1 · Mar 19, 2026 · US
CDK inhibitors and uses thereof
US-12486280-B2 · Dec 2, 2025 · US
ERK inhibitors and uses thereof
US-12428416-B2 · Sep 30, 2025 · US
Select kras g12c inhibitors and uses thereof
US-2025136582-A1 · May 1, 2025 · US
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
US-2024300892-A1 · Sep 12, 2024 · US
Mcl1 inhibitors and uses thereof
US-2023116602-A1 · Apr 13, 2023 · US
CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer
US-11407721-B2 · Aug 9, 2022 · US
Kras g12c inhibitors and uses thereof
US-2022227738-A1 · Jul 21, 2022 · US
Prmt5 inhibitors and uses thereof
US-2022194949-A1 · Jun 23, 2022 · US
Recent patents
Latest publications not already listed above.
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
US-2022169611-A1 · Jun 2, 2022 · US
Benzimidazole derivatives and their uses
US-11332459-B2 · May 17, 2022 · US
Cdk inhibitors and uses thereof
US-2022106325-A1 · Apr 7, 2022 · US
Erk inhibitors and uses thereof
US-2022002294-A1 · Jan 6, 2022 · US
KRAS G12C inhibitors and methods of using the same
US-11096939-B2 · Aug 24, 2021 · US
KRAS G12C inhibitors and methods of using the same
US-11045484-B2 · Jun 29, 2021 · US
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
US-2021179560-A1 · Jun 17, 2021 · US
KRAS G12C inhibitors and methods of using the same
US-10988485-B2 · Apr 27, 2021 · US
Benzimidazole derivatives and their uses
US-2020308145-A1 · Oct 1, 2020 · US
Kras g12c inhibitors and methods of using the same
US-2020030324-A1 · Jan 30, 2020 · US
Kras g12c inhibitors and methods of using the same
US-2019345169-A1 · Nov 14, 2019 · US
Kras g12c inhibitors and methods of using the same
US-2019336514-A1 · Nov 7, 2019 · US
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
US-2019062276-A1 · Feb 28, 2019 · US
Cis-morpholinone and other compounds as mdm2 inhibitors for the treatment of cancer
US-2018354918-A1 · Dec 13, 2018 · US
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
US-2017144971-A1 · May 25, 2017 · US
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
US-9593129-B2 · Mar 14, 2017 · US
Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
US-9376425-B2 · Jun 28, 2016 · US
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
US-2016137667-A1 · May 19, 2016 · US
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
US-9296736-B2 · Mar 29, 2016 · US
Cis-morpholinone and other compounds as mdm2 inhibitors for the treatment of cancer
US-2016002185-A1 · Jan 7, 2016 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Amgen Inc | 22 |
| 1200 Pharma Llc | 9 |
| Univ California | 9 |
| California Inst Of Techn | 8 |
| Teijin Pharma Ltd | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 26 |
| A61P35/02 | 16 |
| A61K31/5377 | 14 |
| C07D471/10 | 14 |
| C07D417/14 | 12 |